Sheila A. Denton joined Incyte in 2023 as Executive Vice President and General Counsel, with more than 30 years of legal, policy and compliance experience across the biopharmaceutical, pharmaceutical and animal health industries.

Prior to joining Incyte, she spent nearly 20 years at Boehringer Ingelheim where she held positions of increasing levels of responsibility, including her most recent position as Senior Vice President, General Counsel and Corporate Secretary. In this role, she was responsible for leading a team of professionals across legal, compliance, governmental affairs and policy functions, focused on providing solution-oriented support for the pharmaceutical and animal health businesses.